Results 151 to 160 of about 1,091,780 (307)
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
U.S. Healthcare Insurance Market Concentration from 2001 to 2016: Increased Growth in Direct Written Premiums and Overall Decreased Market Consolidation. [PDF]
Cureus, 2020 Ng MK +10 more
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
LIBERALIZATION AND MARKET CONCENTRATION IN THE INSURANCE INDUSTRY: CASE OF CROATIA
Economic Review, 2011 This paper analyzes market concentration on the market of insurance companies in Croatia. For a very long time, Croatian insurance market was dominated by one company.
Lorena Škuflić +2 more
doaj
Large-Scale Disasters and the Insurance Industry [PDF]
We investigate the impact of the 20 largest – in terms of insured losses – man-made or natural disasters on various insurance industry stock indices. We show via an event study that insurance sectors worldwide are quite resilient, in a market–value sense,
Sebastian Schich, Walter Kraemer
core
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
British Journal of Clinical Pharmacology, EarlyView.Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
The use of market information in pricing deposit insurance [PDF]
An argument that information about the value of the deposit-insurance guarantee is available from market-generated data.Deposit ...
James B. Thomson
core
British Journal of Clinical Pharmacology, EarlyView.Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
European Insurance Law: A Single Insurance Market?
, 2000 Digitised version produced by the EUI Library and made available online in 2020.
openaire +2 more sources
"Prescription for Health Care Policy, The Case for Retargeting Tax Subsidies to Health Care" [PDF]
With health care delivery increasingly shaped by market and budgetary discipline, the provision of health care for all seems an ever-more-distant goal.The high cost of American health care is the inevitable by-product of its method of financing.
Walter M. Cadette
core